SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549
--------------------------------------------------------------------------------

                                   FORM 10-QSB
(Mark  One)
/ X /    ANNUAL  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
         EXCHANGE  ACT  OF  1934
For  the  quarter  ended  September  30,  2000

                                       OR

/   /    TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
         EXCHANGE  ACT  OF  1934
For  the  transition  period  from  ________  to  _________

                     Commission file number     33-96882-LA
                                                -----------

                       CARING PRODUCTS INTERNATIONAL, INC.
                 (Name of small business issuer in its charter)
                              ____________________

            DELAWARE                                         98-0134875
(State  or other jurisdiction of               (IRS Employer Identification No.)
incorporation  or  organization)               ____________________


                     PO BOX 9288,  SEATTLE, WASHINGTON 98109
                           (principal mailing address)

                                 (206) 523-7065
                (Issuer's telephone number, including area code)
                              ____________________

     Securities  registered  under Section 12(b) of the Exchange Act:      None.

     Securities registered under Section  2(g) of the  Exchange  Act:
          Common  Stock,  $.01  par  value
          Warrants  to  purchase  common  stock.

Check  whether  the  issuer:     (1)  filed  all reports required to be filed by
Section  13 or 15 (d) of the Exchange Act during the past 12 months (or for such
shorter  period  that the registrant was required to file such reports), and (2)
has  been  subject  to  such  filing  requirements  for  the  past  90  days.
Yes  X        No
     -

Check  if there is no disclosure of delinquent filers in response to Item 405 of
Regulation  S-B  contained in this form, and no disclosure will be contained, to
the  best  of  registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in Part III of this Form 10-QSB.  / X /

                   ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                           DURING THE PAST FIVE YEARS
     Not  applicable.
                       APPLICABLE ONLY TO CORPORATE REGISTRANTS

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity,  as of  November 3, 2000: 3,056,343 shares of common stock, $.01
par  value  (the  "Common  Stock").

     Transitional  Small  Business  Disclosure  Format  (check  one):
Yes          No     X
                       DOCUMENTS INCORPORATED BY REFERENCE

Part  III  -  Certain exhibits                    Included in prior filings made
Listed in response to Item 13(a)               under the Securities Act of 1933.


1
<PAGE>
<TABLE>
<CAPTION>
                       CARING PRODUCTS INTERNATIONAL, INC
                                   FORM 10-QSB
                     FOR THE PERIOD ENDED SEPTEMBER 30, 2000


     INDEX                                                                    PAGE  NUMBER


PART  I:  FINANCIAL  INFORMATION
<S>                                                                               <C>
     Item 1  Financial Statements

             Consolidated Balance Sheets at March 31, 2000 and September 30, 2000     3
                  (unaudited for September 30, 2000 period)

             Consolidated Statements of Operations for the three and six-month
             periods ended September 30, 1999 and September 30,  2000                 4
                  (unaudited)

             Consolidated Statements of Cash Flows for the six-month
             periods ended September 30, 1999 and September 30, 2000                  5
                  (unaudited)

             Notes to Unaudited Consolidated Financial Statements                     6


     Item 2  Managements Discussion and Analysis of
               Financial Condition and Results of Operations                          7


PART II  OTHER INFORMATION                                                            9
</TABLE>


2
<PAGE>
<TABLE>
<CAPTION>
                 CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                               CONSOLIDATED BALANCE SHEETS



                                           ASSETS

                                                                              SEPTEMBER 30,
                                                                MARCH 31,         2000
                                                                  2000         (UNAUDITED)
                                                             ---------------  -------------
<S>                                                          <C>              <C>
Current Assets
  Cash                                                       $      181,763   $     13,238
  Accounts receivable less allowance
     of $3,026 at March 31, 2000 and September 30, 2000              57,498          8,254
  Inventories                                                        15,715          6,380
  Prepaid expenses                                                   24,091          4,096
                                                             ---------------  -------------

          Total current assets                                      279,067         31,968

  Equipment, net                                                     20,338         15,484
                                                             ---------------  -------------

                                                             $      299,405   $     47,452
                                                             ===============  =============


            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current Liabilities
  Accounts payable                                           $      107,945   $     82,163
  Accrued salaries                                                    9,465         12,499
  Accrued liabilities                                                15,156              -
                                                             ---------------  -------------

          Total current liabilities                                 132,566         94,662
Stockholders' equity (deficit)
  Preferred stock, par value $0.01 per share; authorized,
    1,000,000 shares; none outstanding                                    -              -
  Common stock, par value $0.01 per share; authorized,
    15,000,000 shares; issued and outstanding, 3,056,343
    in March 31, 2000 and September 30, 2000, respectively           30,564         30,564
  Additional paid-in capital                                     19,232,069     19,232,069
  Accumulated deficit                                           (19,095,794)   (19,309,843)
                                                             ---------------  -------------

          Total stockholders' equity (deficit)                      166,839        (47,210)
                                                             ---------------  -------------

                                                             $      299,405   $     47,452
                                                             ===============  =============
</TABLE>


           See accompanying notes to consolidated financial statements


3
<PAGE>
<TABLE>
<CAPTION>
              CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                THREE AND SIX MONTH PERIODS ENDED SEPTEMBER 30,
                                1999 AND 2000
                                 (UNAUDITED)


                                     THREE MONTH PERIODS        SIX MONTH PERIODS
                                     ENDED SEPTEMBER 30,       ENDED SEPTEMBER 30,
                                      1999         2000         1999         2000
                                   -----------  -----------  -----------  -----------
<S>                                <C>          <C>          <C>          <C>
Revenues                           $  130,081   $   48,150   $  284,116   $   84,400
Cost of sales                          68,272        4,721      116,227        9,335
                                   -----------  -----------  -----------  -----------

        Gross profit                   61,809       43,429      167,889       75,065

Operating expenses
  Selling                              49,567       22,765      117,187       40,196
  General and administrative          115,370      113,176      476,264      270,158
  Amortization and depreciation         9,428            -       33,123        4,854
                                   -----------  -----------  -----------  -----------

        Total operating expenses      174,365      135,941      626,574      315,208
                                   -----------  -----------  -----------  -----------

        Loss from operations         (112,556)     (92,512)    (458,685)    (240,143)

Other income (expense)
  Other income                        189,426       18,689      204,424       26,094
  Interest expense                          -            -         (741)           -
  Loss on sale of assets                    -            -      (84,176)           -
                                   -----------  -----------  -----------  -----------

                                      189,426       18,689      119,507       26,094
                                   -----------  -----------  -----------  -----------

        Net loss                   $   76,870   $  (73,823)  $ (339,178)  $ (214,049)
                                   -----------  -----------  -----------  -----------


  Weighted average common shares    3,056,343    3,056,343    3,056,343    3,056,343
                                   ===========  ===========  ===========  ===========
    outstanding

  Net loss per common share,       $     0.03   $    (0.02)  $    (0.11)  $    (0.07)
                                   ===========  ===========  ===========  ===========
    primary and dilutive
</TABLE>


           See accompanying notes to consolidated financial statements


4
<PAGE>
<TABLE>
<CAPTION>
              CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
              SIX MONTH PERIODS ENDED SEPTEMBER 30, 1999 AND 2000
                                   (UNAUDITED)



                                                              SEPTEMBER 30,    SEPTEMBER 30,
Increase (Decrease) in Cash                                       1999             2000
                                                             ---------------  ---------------
<S>                                                          <C>              <C>
Cash flows from operating activities
  Net loss                                                   $     (339,178)  $     (214,049)
  Adjustments to reconcile net loss to net cash provided by
    (used in) operating activities
    Amortization and depreciation                                    33,123            4,854
    Issuance of restricted common stock to employees                 55,000                -
    Loss from disposal of equipment                                  84,176                -
    Discounted accounts payable                                     (37,630)               -
    Changes in operating assets and liabilities
      Customer sales account deposit                               (183,981)               -
      Accounts receivable                                           278,942           49,244
      Inventories                                                   293,411            9,335
      Prepaid expenses                                                    -           19,995
      Other assets                                                   12,198                -
      Accounts payable                                             (136,052)         (25,782)
      Accrued liabilities                                            (2,936)         (12,122)
                                                             ---------------  ---------------
        Net cash provided by (used in) operating activities          57,073         (168,525)

Cash flows from investing activities
  Proceeds from sale of equipment                                     1,351                -
                                                             ---------------  ---------------
        Net cash provided by investing activities                     1,351                -

Decrease in cash                                                     58,424         (168,525)

Cash at beginning of period                                         707,847          181,763
                                                             ---------------  ---------------

Cash at end of period                                        $      766,271   $       13,238
                                                             ===============  ===============

Supplemental cash flow information:
  Cash paid for interest                                     $          741   $            -
                                                             ===============  ===============

Noncash investing and financing activities:
  Net book value of assets spun off to Creative Products     $      151,866   $            -
                                                             ===============  ===============
</TABLE>


           See accompanying notes to consolidated financial statements


5
<PAGE>
                       CARING PRODUCTS INTERNATIONAL, INC.
                                AND SUBSIDIARIES
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
        SIX MONTH PERIOD ENDED SEPTEMBER 30, 1999 AND SEPTEMBER 30, 2000



NOTE  1  -  FINANCIAL  STATEMENTS

     The  unaudited  consolidated  financial  statements  and related  notes are
     presented  as  permitted  by  Form  10-QSB  and  do  not  contain   certain
     information  included  in  the  Company's  audited  consolidated  financial
     statements  and  notes for the  fiscal  year  ended  March  31,  2000.  The
     information  furnished  reflects,   in  the  opinion  of  management,   all
     adjustments,  consisting of normal recurring accruals, necessary for a fair
     presentation of the results of the interim periods  presented.  The results
     of operation for the interim periods are not necessarily  indicative of the
     results to be expected  for the entire  fiscal year ending  March 31, 2001.
     The accompanying  unaudited  consolidated  financial statements and related
     notes should be read in conjunction with the audited consolidated financial
     statements and the Form 10-KSB of Caring Products  International,  Inc. and
     its  subsidiaries  (the  "Company") and notes thereto,  for its fiscal year
     ended March 31, 2000.

NOTE  2  -  LOSS  PER  COMMON  SHARE

     The Company accounts for loss per common share under Statement of Financial
     Accounting  Standards  No  128,  "Earnings  Per  Share"  which  established
     standards for computing and presenting  earnings per share.  Loss per share
     is based on the weighted average number of common shares outstanding during
     each  period and income  available  to common  stockholders.  The  weighted
     average  number of common  shares was 3,056,343 for the three and six-month
     periods ended  September  30, 1999 and  September  30, 2000.  The effect of
     common  equivalent  shares on the  computation  of loss per share  assuming
     dilution for the six months ended September 30, 1999 and September 30, 2000
     was anti-dilutive and therefore is not included.

NOTE  3  -  INVENTORIES

     Inventories  consisted  of  finished  goods and are  stated at the lower of
     cost,  as  determined by the  first-in,  first-out  method,  or market (net
     realizable  value).  At the end of Fiscal Year 2000, the Company wrote down
     $166,153 of  inventory to account for certain  products  that were held for
     more than a 12 month period,  products  specifically  packaged for a retail
     chain or a specific market in which the Company's products are no longer in
     active  distribution,  to  reflect  reduced  sales  activity  from  lack of
     advertising and the  expectation  that the Company will sell such inventory
     at  substantial  discounts  or  dispose  through  charitable  donations  to
     hospitals  or  relief   organizations.   The  Company  closed  one  of  its
     fulfillment  centers  on or about June 30,  2000 and may close more  during
     Fiscal 2001.

NOTE  4  -  AGREEMENT  TO  MERGE

     During July 2000,  the  Company  signed a  non-binding  letter of intent to
     merge with a digital imaging product  company.  The agreement  provides for
     the Company to issue  approximately  30 million  shares of common  stock as
     part of the proposed  transaction upon closing.  During September 2000, the
     Company  announced  that the  proposed  merger  has been  delayed  due to a
     dissident minority  shareholder and the failure of both companies to sign a
     definitive  agreement to merge. The Company continues to negotiate with the
     principals  of the  digital  imaging  company  as  well  as  explore  other
     transactions and business opportunities.

NOTE  5  -  GOING  CONCERN

     The Company incurred a net loss of $339,178 and $214,049 for the six months
     ended September 30, 1999 and 2000,  respectively.  The Company's ability to
     continue  as a going  concern is  contingent  upon its  ability to maintain
     positive cash flow from  operating and  financing  activities.  The Company
     continues to review all its strategic options.


6
<PAGE>
ITEM  2.     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

THE  FOLLOWING  ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL CONDITION OF
THE  COMPANY  SHOULD  BE  READ  IN  CONJUNCTION  WITH THE CONSOLIDATED FINANCIAL
STATEMENTS,  INCLUDING  THE NOTES THERETO, OF THE COMPANY CONTAINED ELSEWHERE IN
THIS  FORM  10-QSB.


OVERVIEW

Caring  Products  International  Inc  and  its  subsidiaries  (collectively  the
"Company" or "CPI") has designed a line of proprietary urinary incontinence pant
and  liner  products  which  have  been  sold  under  the  Rejoice  trade  name.
Historically,  the  Company's  customer  base  has been retail drug stores, home
healthcare  companies,  surgical  supply  stores  and  national  drug  wholesale
companies.  Given  the  high  costs  associated  with increasing and maintaining
distribution  for  its incontinence products at larger retail drug chain stores,
increased  competition,  and  executive  management  changes, in early 1999, the
Company  announced its intent to evaluate all of its strategic options including
licensing  the  Company's  products,  merging  with  another  company, potential
acquisitions,  obtaining  new  sources  of equity and cost-cutting measures.  As
part of the Company's cost cutting measures, the Company ceased paid advertising
to  consumers  and participation in costly in-store chain promotions which are a
requirement  to remain on the shelves of many large drug store chains in the US.
The  Company  further  reduced  its  payroll  and  other  administrative  costs.

As  part  of  the  Company's  restructuring  efforts,  on December 23, 1999, the
Company  spun-off  its  wholly-owned  subsidiary Creative Products International
Inc.  to  shareholders  of  record  on  June  30,  1999.

During  the  period  ended  September 30, 2000, the Company's sales continued to
decline  and  the Company expects that it will continue to lose money due to the
administrative  costs  of  maintaining  a  public  company  and winding down its
inventories.  The Company closed one if its product fulfillment centers and will
continue  to  close  more  of  its  fulfillment centers during Fiscal 2001.  The
Company  is  not  under contractual obligation and may close any facility at any
time.


RESULTS  OF  OPERATIONS  AND  OPERATING  EXPENSES

Revenues  decreased  from $130,081 in the three-month period ended September 30,
1999 to $48,150 in the comparable 2000 Period, a 63% decrease.  Revenues for the
six-month  1999  Period  was $284,116, compared to $84,400 in the 2000 Period, a
70% decrease.  The decrease was a result of declining distribution of Rejoice in
drug  stores,  discontinued  support  of  the  brand  in  consumer  advertising,
increased  problems for long-term consumers to find a local source of supply for
the  brand,  and  lack  of  available products sold in the quantities and styles
desired  by  consumer  healthcare  products.

Cost  of  sales decreased from $68,272 for the 1999 three month Period to $4,721
in  the  2000  Period,  a decrease of 93%.   Cost of sales in the six month 1999
period  were  $116,227,  compared  to $9,335 in the 2000 period, a 92% decrease.
This  decrease  is  primarily  attributable  to  reductions in sales and sale of
certain inventory which had been written down during the Fiscal Year ended March
31, 2000. The Company did not add to its inventory through new production during
the  period.

For  the  three month period ended 2000, the Company generated a gross profit of
$43,429  as  compared  to  a  gross  profit of $61,809 in the September 30, 1999
Period,  a  30% reduction.  The gross profit for the six-month period ended 1999
was  $167,889, and $75,065 in the 2000 period, a 55% decrease. This reduction in
gross  profit  reflected  the  comparable  decrease  in  sales  activity.

Total  operating  expenses  decreased from $174,365 in the three month September
1999  Period  to  $135,941  in  the three month September 30, 2000 Period, a 22%
decrease.  The operating expenses in the six-month 1999 period were $626,574 and
$315,208  in  the  2000  period,  a  50%  decrease.  This  decrease reflects the
implementation  of the Company's cost cutting programs which included reductions
in  payroll,  sales  and advertising, product storage and distribution, customer
service  and  other  administration  associated with serving a national consumer
base  which  purchases  products through chain drug stores to a smaller consumer
base  which  purchases  products  through  direct mail, regional drug stores and
catalogs.


7
<PAGE>
Selling  costs  decreased  54%  from  $49,567  in the three month 1999 Period to
$22,765 in the 2000 Period due to the reductions in sales and shipping expenses.
The  selling  costs  in  the  six-month  1999  period decreased from $117,187 to
$40,196  in  the  2000  Period,  a  66%  decrease.

General  and  administrative  expenses  decreased  2% from $115,370 in the three
month  1999  Period  to  $113,176 in the 2000 Period.  Accounting and legal fees
continued  to  be  a significant portion of administration costs due to specific
filing,  accounting  and  negotiation  of  the proposed merger.  The general and
administrative  expenses in the six-month 1999 period were $476,264 and $270,158
in  the 2000 period, a 43% decrease.  These expenses were primarily attributable
to  the  costs  of maintaining a public company and closing down its operations.

 Depreciation  and  amortization  expense  were  $9,428  in the three month 1999
Period  and  $0  in  the  2000  Period.  For  the  six-month  1999  period,  the
depreciation  and amortization was $33,123 and $4,854 in the 2000 period, an 85%
decrease.   The  decrease was attributable to the transfer of assets to Creative
Products International Inc. which was subsequently spun-off to shareholders as a
separate  operating  company  and  the  write  off  of  certain  equipment.

The  interest  expense decreased from $741 in the six month 1999 period to $0 in
2000.  This  decrease  was  attributable  to  the  elimination  of  short-term
obligations.  Other  income  of  $18,689  in  the  three  month  2000 Period was
attributable  to  the  write  off  of  office equipment lease obligations, a 90%
decrease compared to $189,426 in the three month 1999 period which was generated
through  the  sale  of  goods and collection of receivables written off in prior
periods.

As  a  result  of  the foregoing, the Company generated a loss of $73,823 in the
three  month  2000  Period  as  compared  to a net profit of $76,870 in the 1999
period.  The  net  loss in the six-month 1999 period was $339,178, compared to a
net  loss  of  $214,049  in  the  six  month  2000  period.

For  the  three  and  six  months  ended September 30, 2000 the number of shares
outstanding  remained  at  3,056,343.

LIQUIDITY  AND  CAPITAL  RESOURCES

The  Company has historically financed its operations through the sale of equity
and  debt.  As  of  September 30, 2000, the Company did not generate new funding
through  the  sale  of  securities, exercise of stock options or warrants or new
debt  to  the  Company  but maintained its operations through sales of remaining
inventory.

As  of  September 30, 2000 the Company's principal sources of liquidity included
cash  of $13,238, net accounts receivable of $8,254 after allowance for doubtful
accounts  of  $3,026  and  inventory  of  $6,380.

The  Company's operating activities used cash of $168,525 in the 2000 Period and
generated  cash  of $57,073 in the 1999 Period.   The Company's future liquidity
will  be dependent on the Company's ability to complete its proposed merger on a
timely  basis,  or  obtain new sources of debt or equity.  There is no assurance
that the Company will be able to generate the funds needed to offset its current
or  future  obligations  on  a  timely  basis.

FORWARD  LOOKING  STATEMENTS

This Form 10-QSB and other reports and statements filed by the Company from time
to time with the Securities and Exchange Commission (collectively the "Filings")
contain or may contain forward-looking statements and information that are based
upon  beliefs  of,  and  information  currently  available  to,  the  Company's
management,  as  well  as  estimates  and  assumptions  made  by  the  Company's
management.

When  used  in  the  Filings,  the  words  "anticipate",  "believe", "estimate",
"expect",  "future", "intend", "plan" and similar expressions, as they relate to
the  Company  or  the Company's management, identify forward-looking statements.
Such  statements  reflect the current view of the Company with respect to future
events  and  are subject to risks, uncertainties and assumptions relating to the
Company's  operations and results of operations, competitive factors and pricing
pressures,  shifts in market demand, the performance and needs of the industries
which  constitute the customers of the Company, the costs of product development
and  other  risks and uncertainties, including, in addition to any uncertainties
with  respect  to  management  of  growth,  increases  in sales, the competitive
environment,  hiring  and  retention  of  employees,  pricing,  new  product
introductions,  product  productivity,  distribution  channels,  enforcement  of
intellectual  property  rights,  possible  volatility of stock price and general
industry  growth  and economic conditions.  Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual  results  may  differ  significantly  from  those  anticipated, believed,
estimated,  expected,  intended  or  planned.


8
<PAGE>
PART  I:  FINANCIAL  INFORMATION


Item  1   Legal  Proceedings.

          None.

Item  2   Changes  in  Securities.

          None

Item  3   Defaults  Upon  Senior  Securities.

          None.

Item  4   Submission  of  Matters  to  a  Vote  of  Security  Holders

          None.

Item  5   Other  Information.

          None.

Item  6   Exhibits

          27.1  --  Financial  Data  Schedule



      SIGNATURES


In  accordance  with  the  requirements of Section 13 or 15(d) of the Securities
Exchange  Act  of  1934,  the  registrant caused this report to be signed on its
behalf  by  the  undersigned, thereunto duly authorized, in the City of Seattle,
Washington,  on  November  11,  2000.


                              CARING  PRODUCTS  INTERNATIONAL,  INC.

                              By:  /s/  Susan  A.  Schreter
                                   - - - - - - - - - - - - - - - - - - - - - - -
                                   Susan  A.  Schreter
                                   Acting  Chairman  of  the  Board  and
                                   CEO


In  accordance  with  the requirements of the Exchange Act, this report has been
signed  by  the  following  persons  on  behalf  of  the  registrant  and in the
capacities  and  on  the  dates  indicated:


     SIGNATURE                       TITLE                       DATE
     ---------                       -----                       ----
/s/  Susan A. Schreter       Acting Chairman and CEO       November 11, 2000
- - - - - - - - - - - - -
Susan  A.  Schreter


<PAGE>